Search Within

Genitourinary Oncology Service

  1. "2021"
Formats
  1. Journal Article (154)
  2. Meeting Abstract (148)
  3. Review (17)
  4. Correspondence (11)
  5. Editorial (6)
  6. Guidelines (2)
  7. Book Section (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Solid Tumor Oncology Division (341)
  2. Department of Medicine (340)
  3. GSK Faculty (90)
  4. Hematology-Oncology Fellows (79)
  5. Epidemiology and Biostatistics (74)
  6. Human Oncology and Pathogenesis Program (74)

More Groups

People
  1. Robert Motzer (65)
  2. Jonathan Rosenberg (48)
  3. David Solit (47)
  4. Michael Morris (42)
  5. Gopakumar Iyer (34)
  6. Dean Bajorin (32)

More People

Years
  1. 2021 (341)
Publications
  1. Journal of Clinical Oncology (103)
  2. Clinical Cancer Research (28)
  3. Annals of Oncology (20)
  4. Cancer Research (15)
  5. Journal for ImmunoTherapy of Cancer (10)
  6. New England Journal of Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (110)
  2. American Association for Cancer Research (46)
  3. Oxford University Press (28)
  4. Elsevier Science, Inc. (20)
  5. Nature Publishing Group (18)
  6. Biomed Central Ltd (14)

More Publishers

Results (341)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Apoptosis resulting from anti-cancer agent activity in vivo is enhanced by biochemical modulation of tumour cell energy
    Book Section

    Martin, D. S.; Stolfi, R. L.; Colofiore, J. R.; Koutcher, J. A.; Alfieri, A.; Sternberg, S.; Nord, L. D.
    In Lavin, M.; Watters, D. (Eds.) Programmed Cell Death: The cellular and molecular biology of apoptosis (2021)

    Fulltext@MSK | Save
  • Novel standards and emerging therapies for systemically treatment-naïve clear cell renal cell carcinoma - A rapidly changing landscape
    Review

    Kotecha, R. R.; Voss, M. H.
    Journal of Cancer Metastasis and Treatment (2021)

    Fulltext@MSK | Save
  • Increasing financial payments from industry to medical oncologists in the United States, 2014-2017
    Journal Article

    Rahman, M. W.; Trivedi, N. U.; Bach, P. B.; Mitchell, A. P.
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save
  • Changes, challenges and opportunities in cancer care during the COVID-19 era and beyond: Building on lessons learned from the pandemic
    Review

    Motzer, R. J.; Jonasch, E. A.; McGregor, B. A.; Figlin, R. A.
    Kidney Cancer Journal (2021)

    Fulltext@MSK | Save
  • Phase 3 study of pembrolizumab + belzutifan + lenvatinib or pembrolizumab/quavonlimab + lenvatinib versus pembrolizumab + lenvatinib as first-line treatment for advanced renal cell carcinoma
    Meeting Abstract

    Choueiri, T.; Plimack, E.; Powles, T.; Voss, M.; Gurney, H.; Silverman, R.; Perini, R.; Rodriguez-Lopez, K.; Rini, B.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • A phase 1b/2 randomized study of Avb-S6-500 in combination with cabozantinib versus cabozantinib alone in patients with advanced clear cell renal cell carcinoma who have received front-line treatment
    Meeting Abstract

    Beckermann, K.; Vogelzang, N.; Shifeng, M.; Ornstein, M.; Shah, N.; Hammers, H.; Campbell, M.; Gao, X.; McDermott, D.; Anderson, R.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • A phase 1a/b study of IK-175, an oral AHR inhibitor, alone and in combination with nivolumab in patients with locally dvanced or metastatic solid tumors and urothelial carcinoma
    Meeting Abstract

    McKean, M.; Luke, J.; Lakhani, N.; Bashir, B.; Aggen, D.; Tan, A.; Kacena, K.; Wang, L.; Timothy, M.; Santillana, S.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Сохраненное время качественной жизни, проведенное без клинических симптомов и проявлений токсичности (Q-TWiST), при лечении комбинацией ленватиниба и эверолимуса по сравнению с монотерапией эверолимусом у пациентов с распространенным почечно-клеточным раком
    Journal Article

    Lee, C. H.; Wan, Y.; Smith, A.; Xie, R.; Motzer, R. J.
    Onkourologiya (2021)

    Fulltext@MSK | Save
  • Quality of life, functioning, and symptoms in patients with previously treated locally advanced or metastatic urothelial carcinoma from EV-301
    Meeting Abstract

    Gurney, H.; Mamtani, R.; Rosenberg, J. E.; Powles, T.; Sonpavde, G. P.; Loriot, Y.; Duran, I.; Lee, J. L.; Matsubara, N.; Vulsteke, C.; more...
    Swiss Medical Weekly (2021)

    Fulltext@MSK | Save
  • Post hoc analysis of the CLEAR study in advanced renal cell carcinoma (RCC): Effect of subsequent therapy on survival outcomes in the lenvatinib (L) plus everolimus (E) vs sunitinib (S) treatment arms
    Meeting Abstract

    Grünwald, V.; Hutson, T.; Choueiri, T. K.; Motzer, R.; Rha, S. Y.; Alyasova, A.; Merchan, J.; Gurney, H.; Peer, A.; Takagi, T.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save